Is the pentavalent rotavirus vaccine necessary?

Rotavirus infection is the leading cause of severe dehydrating diarrhea in children under 5 years of age worldwide. Vaccination is an effective means of preventing rotavirus infection; therefore, timely immunization is essential.

Rotavirus vaccine is classified as a Category II vaccine—administered voluntarily and at the recipient’s own expense. Parents may decide whether or not to vaccinate their child based on the infant’s age and individual needs.

The protective effect of rotavirus vaccines lasts up to 7 years, covering the period during which infants and young children are most susceptible to infection. Currently, two rotavirus vaccines are available: one may be administered starting at 6 weeks of age, and the other from 2 months of age. Notably, according to the product labeling, the first dose of the pentavalent rotavirus vaccine must be administered between 6 and 12 weeks of age; vaccination is contraindicated beyond this window.

Compared with the monovalent oral rotavirus live attenuated vaccine, the oral pentavalent reassortant rotavirus live attenuated vaccine offers broader serotype coverage and superior efficacy. However, due to its strict age restrictions, infants older than 12 weeks of age are eligible only for the monovalent oral rotavirus live attenuated vaccine. Parents should select the appropriate vaccine based on their child’s specific circumstances.